Rubius Therapeutics, Inc.
ARTIFICIAL ANTIGEN PRESENTING CELLS AND METHODS OF USE
Last updated:
Abstract:
The present disclosure relates to artificial antigen presenting cells (aAPCs), in particular engineered erythroid cells and enucleated cells (e.g. enucleated erythroid cells and platelets), that are engineered to activate or suppress T cells.
Status:
Application
Type:
Utility
Filling date:
22 Dec 2018
Issue date:
26 Sep 2019